MyAverix Finance
US · Healthcare
Gracell Biotechnologies Inc. (GRCL)
Biotechnology
Gracell Biotechnologies Inc. (GRCL) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-22, reported market cap is $989.87M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GRCL
Gracell Biotechnologies Inc. (GRCL) — FAQ
What is Gracell Biotechnologies Inc.'s market cap?
Gracell Biotechnologies Inc. (GRCL) has a reported market cap of $989.87M (data as of 2026-05-22).
What is GRCL's P/E ratio?
The price-to-earnings (P/E) ratio for Gracell Biotechnologies Inc. (GRCL) is 25.00 (data as of 2026-05-22).
Does Gracell Biotechnologies Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Gracell Biotechnologies Inc. (GRCL). Check the MyAverix Finance app for the latest dividend data.
What sector is Gracell Biotechnologies Inc. in?
Gracell Biotechnologies Inc. (GRCL) is classified in the Healthcare sector (Biotechnology industry).
What exchange is GRCL listed on?
GRCL is listed on US.
What is Gracell Biotechnologies Inc.'s net margin?
Gracell Biotechnologies Inc. (GRCL) reports a net margin of 0.0% (data as of 2026-05-22).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.